• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form FWP filed by Colgate-Palmolive Company

    11/3/25 4:31:42 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $CL alert in real time by email
    FWP 1 tm2530079d2_fwp.htm FWP

    Dated November 3, 2025

    Free Writing Prospectus Filed Pursuant to Rule 433

    Supplementing Prospectus dated October 27, 2023 and
    Prospectus Supplement dated November 3, 2025
    Registration Statement No. 333-275201

    €600,000,000
    Colgate-Palmolive Company
    3.250% Senior Notes due 2035



    Final Term Sheet

     

    Issuer: Colgate-Palmolive Company
    Anticipated Ratings:
    (Moody’s/S&P)*
    Aa3/A+ (stable)/(stable)
    Trade Date: November 3, 2025
    Settlement Date:** November 10, 2025 (T+5)
    Joint Book-Running Managers:

    Barclays Bank PLC
    Banco Bilbao Vizcaya Argentaria, S.A.

     

    Co-Managers:

    ANZ Securities, Inc.

    BNP PARIBAS

    BNY Mellon Capital Markets, LLC 

    Citigroup Global Markets Limited

    Goldman Sachs & Co. LLC 

    HSBC Bank plc

    ICBC Standard Bank Plc

    J.P. Morgan Securities plc

    Merrill Lynch International

    Morgan Stanley & Co. International plc

    Scotiabank (Ireland) Designated Activity Company

    U.S. Bancorp Investments, Inc.

    CastleOak Securities, L.P.

    Siebert Williams Shank & Co., LLC

     

    London Paying Agent: The Bank of New York Mellon, London Branch
    Stabilization: Stabilization/FCA
    Security Description: SEC-registered 10-year 3.250% Senior Notes (the “Notes”)
    Principal Amount: €600,000,000
    Currency of Payment: Euro
    Maturity Date: November 10, 2035
    Interest Payment Dates: Payable annually in arrears on November 10 of each year, commencing November 10, 2026
    Day Count Convention: ACTUAL/ACTUAL (ICMA)
    Interest Rate: 3.250% per annum
    Pricing Benchmark: 10-year EUR mid-swap

     

     

     

     

    Pricing Benchmark Yield: 2.669%
    Re-offer Spread vs. Pricing Benchmark: MS +70 bps
    Re-offer Yield (annual): 3.369%
    Government Benchmark: DBR 2.600% due August 15, 2035
    Government Benchmark Price and Yield: 99-425; 2.666%
    Re-offer Spread vs. Government Benchmark: B +70.3 bps
    Price to Public: 99.004% plus accrued interest, if any, from November 10, 2025
    Gross Proceeds: €594,024,000
    Optional Redemption:  

    At any time prior to August 10, 2035 (the date that is three months prior to the maturity date of the Notes) at a discount rate of Comparable Government Bond Rate plus 15 basis points, plus accrued and unpaid interest to the redemption date.

     

    At any time on or after August 10, 2035 (the date that is three months prior to the maturity date of the Notes) at a redemption price equal to 100% of the principal amount of the Notes being redeemed, plus accrued and unpaid interest to, but excluding, the redemption date.

    Payment of Additional Amounts: Yes, subject to the customary exceptions described in the preliminary prospectus supplement dated November 3, 2025 (the “Preliminary Prospectus Supplement”).
    Redemption for Tax Reasons: Yes, as described in the Preliminary Prospectus Supplement.
    Listing: The Issuer intends to apply to list the Notes on the New York Stock Exchange.
    Minimum Denominations: €100,000 and integral multiples of €1,000 in excess thereof
    CUSIP/ISIN/Common Code: 194162 AU7 / XS3223273668 / 322327366

     

     

    *Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.

     

    **It is expected that delivery of the Notes will be made against payment therefor on or about November 10, 2025, which is the fifth business day following the date hereof (such settlement cycle being referred to as “T+5”). Under the E.U. Central Securities Depositaries Regulation, trades in the secondary market generally are required to settle in two business days in the place of settlement unless the parties to a trade expressly agree otherwise. Also, under Rule 15c6-1 under the Securities Exchange Act of 1934, as amended, trades in the secondary market generally are required to settle in one New York business day, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Notes on any date prior to the first or second business day, as applicable, prior to the settlement date will be required, by virtue of the fact that the Notes initially will settle in T+5 settlement, to specify any alternative settlement arrangements to prevent a failed settlement.

     

    The issuer has filed a registration statement (including a prospectus) with the U.S. Securities and Exchange Commission (the “SEC”) for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling Barclays Bank PLC at 1-888-603-5847 or Banco Bilbao Vizcaya Argentaria, S.A. at +1-800-422-8692.

     

     

     

     

    MiFID II / UK MiFIR professionals/ECPs-only / No PRIIPs or UK PRIIPs KID — Manufacturer target market (MiFID II / UK MiFIR product governance) is eligible counterparties and professional clients only (all distribution channels). No PRIIPs / UK PRIIPs key information document (KID) has been prepared as the Notes are not available to retail investors in the European Economic Area or the United Kingdom.

     

    In the United Kingdom, this final term sheet is for distribution only to persons who (i) have professional experience in matters relating to investments and qualifying as investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the “Financial Promotion Order”), (ii) are persons falling within Article 49(2)(a) to (d) (“high net worth companies, unincorporated associations etc.”) of the Financial Promotion Order, or (iii) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000 (as amended, the “FSMA”)) in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as “relevant persons”). In the United Kingdom, this final term sheet is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this document relates is available in the United Kingdom only to relevant persons and, in the United Kingdom, will be engaged in only with relevant persons.

     

    The securities described in this final term sheet are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the United Kingdom. For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client, as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018 (as amended, the “EUWA”) or (ii) a customer within the meaning of the provisions of the FSMA and any rules or regulations made under the FSMA to implement Directive (EU) 2016/97 (as amended), where that customer would not qualify as a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law of the United Kingdom by virtue of the EUWA. Consequently no key information document required by Regulation (EU) No 1286/2014 (as amended) as it forms part of domestic law of the United Kingdom by virtue of the EUWA (the “UK PRIIPs Regulation”) for offering or selling the securities described in this final term sheet or otherwise making them available to retail investors in the United Kingdom has been prepared and therefore offering or selling such securities or otherwise making them available to any retail investor in the United Kingdom may be unlawful under the UK PRIIPs Regulation.

     

    The securities described in this final term sheet are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the European Economic Area. For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, “MiFID II”) or (ii) a customer within the meaning of Directive (EU) 2016/97 (as amended), where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II. Consequently no key information document required by Regulation (EU) No 1286/2014 (as amended, the “PRIIPs Regulation”) for offering or selling the securities described in this final term sheet or otherwise making them available to retail investors in the European Economic Area has been prepared and therefore offering or selling such securities or otherwise making them. available to any retail investor in the European Economic Area may be unlawful under the PRIIPs Regulation

     

    ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR BELOW ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM.

     

     

     

     

    Get the next $CL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CL

    DatePrice TargetRatingAnalyst
    1/13/2026$86.00Underweight → Equal Weight
    Wells Fargo
    1/7/2026$88.00Neutral → Overweight
    Piper Sandler
    12/11/2025Buy → Hold
    Argus
    12/9/2025$88.00Sector Perform → Outperform
    RBC Capital Mkts
    10/3/2025$84.00Neutral
    Piper Sandler
    10/28/2024$105.00 → $101.00Buy → Hold
    Stifel
    9/24/2024$121.00Overweight
    Piper Sandler
    9/16/2024$100.00Equal Weight → Underweight
    Wells Fargo
    More analyst ratings

    $CL
    SEC Filings

    View All

    Colgate-Palmolive Company filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - COLGATE PALMOLIVE CO (0000021665) (Filer)

    3/17/26 4:33:28 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate-Palmolive Company filed SEC Form 8-K: Leadership Update

    8-K - COLGATE PALMOLIVE CO (0000021665) (Filer)

    3/12/26 4:33:16 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 10-K filed by Colgate-Palmolive Company

    10-K - COLGATE PALMOLIVE CO (0000021665) (Filer)

    2/23/26 4:03:31 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Growth Officer Hazlin John covered exercise/tax liability with 6,117 shares and was granted 12,803 shares, increasing direct ownership by 38% to 24,422 units (SEC Form 4)

    4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)

    2/25/26 4:26:06 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    CLO and Secretary Daniels Jennifer was granted 25,742 shares and covered exercise/tax liability with 12,351 shares, increasing direct ownership by 18% to 89,844 units (SEC Form 4)

    4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)

    2/25/26 4:18:59 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    EVP and Controller Malcolm Gregory was granted 6,268 shares and covered exercise/tax liability with 2,260 shares, increasing direct ownership by 34% to 15,898 units (SEC Form 4)

    4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)

    2/25/26 4:18:03 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NYSE Content Update: Two-time Olympic Champions Have a Bell Moment on the Trading Floor

    NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, March 13, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastornardi delivers the pre-market update on March 13thU.S. stock market indices are on track for weekly losses as ICE Brent Crude oil, the international benchmark, rises amid the conflict in Iran.On NYSE Live, Bitcoin Standard Treasury Company Co-Founder and CIO Sean Bill will share how his company is working to maximize bitcoin's value.Rugby will meet the NYSE as th

    3/13/26 8:55:00 AM ET
    $CL
    $ICE
    $NOW
    Package Goods/Cosmetics
    Consumer Discretionary
    Investment Bankers/Brokers/Service
    Finance

    Colgate-Palmolive Announces Quarterly Dividend Increase and Elects Christopher Boerner, Ph.D. to Board of Directors

    The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today announced an increase in the quarterly common stock cash dividend to $0.53 up from $0.52 per share. The increase will be effective in the second quarter, 2026. The Board declared that the second quarter dividend is to be paid on May 15, 2026, to shareholders of record on April 20, 2026. On an annualized basis, the new dividend rate is $2.12 versus $2.08 per share previously. The Company has paid uninterrupted dividends on its common stock since 1895. Separately, the Company also announced today that Christopher Boerner, Ph.D., Board Chair and Chief Executive Officer of Bristol-Myers Squibb Company ("Bristol Myers Squibb")

    3/12/26 4:30:00 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate-Palmolive Webcasts Fireside Chat at the UBS Global Consumer and Retail Conference 2026

    Colgate-Palmolive (NYSE:CL) Chief Investor Relations Officer and EVP, M&A, John Faucher, will participate in a fireside chat at the UBS Global Consumer and Retail Conference on Wednesday, March 11, 2026 at 2:00 p.m. ET. Investors may access a live webcast of this fireside chat on Colgate's website at www.colgatepalmolive.com. For those unable to participate during the live webcast, a recorded version of the webcast will be made available through the ‘Investor Center' page of Colgate's website. * * * Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home

    2/25/26 9:30:00 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Colgate-Palmolive upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Colgate-Palmolive from Underweight to Equal Weight and set a new price target of $86.00

    1/13/26 8:40:58 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate-Palmolive upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded Colgate-Palmolive from Neutral to Overweight and set a new price target of $88.00

    1/7/26 8:42:57 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate-Palmolive downgraded by Argus

    Argus downgraded Colgate-Palmolive from Buy to Hold

    12/11/25 8:17:14 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    Financials

    Live finance-specific insights

    View All

    Colgate-Palmolive Announces Quarterly Dividend Increase and Elects Christopher Boerner, Ph.D. to Board of Directors

    The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today announced an increase in the quarterly common stock cash dividend to $0.53 up from $0.52 per share. The increase will be effective in the second quarter, 2026. The Board declared that the second quarter dividend is to be paid on May 15, 2026, to shareholders of record on April 20, 2026. On an annualized basis, the new dividend rate is $2.12 versus $2.08 per share previously. The Company has paid uninterrupted dividends on its common stock since 1895. Separately, the Company also announced today that Christopher Boerner, Ph.D., Board Chair and Chief Executive Officer of Bristol-Myers Squibb Company ("Bristol Myers Squibb")

    3/12/26 4:30:00 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate-Palmolive Company Announces 4th Quarter and Full Year 2025 Results

    Colgate-Palmolive Company (NYSE:CL): Full Year Net sales and Organic sales* increased 1.4%, including a 0.7% negative impact from lower private label pet volume GAAP EPS declined 25% to $2.63, driven by goodwill and intangible assets impairment charges related to the skin health business Base Business EPS* increased 3% to $3.69 Net cash provided by operations was a record $4,198 for the full year Returned $2.9 billion in cash to shareholders through dividends and share repurchases Full Year Total Company Results (GAAP) ($ in millions except per share amounts) 2025 2024 Change Net Sales $20,382 $20,101 +1.4% EP

    1/30/26 6:55:00 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate-Palmolive Webcasts 2025 Fourth Quarter & Full Year Earnings Conference Call January 30, 2026 – 8:30 a.m. ET

    Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2025 fourth quarter and full year earnings conference call on Friday, January 30, 2026, at 8:30 a.m. ET. The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief Financial Officer, Stan Sutula, and Chief Investor Relations Officer and EVP, M&A, John Faucher. Investors may access the earnings press release, prepared materials and the live audio webcast on Colgate's website at https://investor.colgatepalmolive.com/events-and-webcasts. For those unable to participate during the live webcast, a recorded version of the webcast will be made available through the Investor Center section of Colgate's website.

    1/16/26 9:30:00 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    Leadership Updates

    Live Leadership Updates

    View All

    Give Kids A Smile Program Celebrates 23rd Year of Providing Free Oral Health Care Services to Underserved Children

    The American Dental Association Foundation's Initiative, with Exclusive National Sponsors Henry Schein and Colgate-Palmolive, Continues to Expand Its Reach, With Nearly 325,500 Children Expected to Receive Care Throughout 2025 The American Dental Association Foundation (ADA Foundation) is celebrating the 23rd year of its Give Kids A Smile® (GKAS) program, which officially launched on Friday, February 7, at the 2025 national kick-off event at Meharry Medical College School of Dentistry. Since its national launch in 2003, GKAS volunteers have provided free oral health education and services to more than 9.5 million underserved children in the U.S. This press release features multimedia. Vi

    2/10/25 6:30:00 AM ET
    $CL
    $HSIC
    Package Goods/Cosmetics
    Consumer Discretionary
    Medical Specialities
    Health Care

    ZO® Skin Health Appoints Industry Veteran Justin Skala as CEO to Continue Strong Growth

    IRVINE, Calif., March 12, 2024 /PRNewswire/ -- ZO® Skin Health, a premium clinical dermatological skincare brand distributed globally through physicians and skincare professionals, today announced the appointment of Justin Skala as Chief Executive Officer. Mr. Skala brings more than 35 years of leadership experience growing high efficacy products through the professional channel, including driving the expansion of the personal care category over his tenure at Colgate-Palmolive, Inc. (NYSE:CL). He succeeds Mark Williams who will continue to serve the company on its Board of Directors.

    3/12/24 1:08:00 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate-Palmolive Company Appoints Lorrie Norrington as Lead Independent Director of the Board

    Colgate-Palmolive Company (NYSE:CL) today announced that its Board of Directors has appointed Lorrie Norrington as Lead Independent Director, effective March 1, 2023. Ms. Norrington will succeed Stephen I. Sadove, the Company's current Lead Independent Director. Mr. Sadove will remain on the Audit and Personnel and Organization Committees of the Colgate Board of Directors. Ms. Norrington joined the Company's Board in September 2015 and currently serves as Chair of the Nominating, Governance and Corporate Responsibility Committee. She brings extensive global corporate leadership, digital, e-commerce and ESG experience to this role, including her experience in several senior management roles

    1/3/23 4:30:00 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Colgate-Palmolive Company (Amendment)

    SC 13G/A - COLGATE PALMOLIVE CO (0000021665) (Subject)

    2/13/24 5:02:36 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form SC 13G/A filed by Colgate-Palmolive Company (Amendment)

    SC 13G/A - COLGATE PALMOLIVE CO (0000021665) (Subject)

    2/9/23 11:15:26 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form SC 13G/A filed by Colgate-Palmolive Company (Amendment)

    SC 13G/A - COLGATE PALMOLIVE CO (0000021665) (Subject)

    2/9/22 3:43:30 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary